Literature DB >> 19903816

A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles.

Etienne A Cartier1, Leonardo A Parra, Tracy B Baust, Marisol Quiroz, Gloria Salazar, Victor Faundez, Loreto Egaña, Gonzalo E Torres.   

Abstract

Synaptic transmission depends on neurotransmitter pools stored within vesicles that undergo regulated exocytosis. In the brain, the vesicular monoamine transporter-2 (VMAT(2)) is responsible for the loading of dopamine (DA) and other monoamines into synaptic vesicles. Prior to storage within vesicles, DA synthesis occurs at the synaptic terminal in a two-step enzymatic process. First, the rate-limiting enzyme tyrosine hydroxylase (TH) converts tyrosine to di-OH-phenylalanine. Aromatic amino acid decarboxylase (AADC) then converts di-OH-phenylalanine into DA. Here, we provide evidence that VMAT(2) physically and functionally interacts with the enzymes responsible for DA synthesis. In rat striata, TH and AADC co-immunoprecipitate with VMAT(2), whereas in PC 12 cells, TH co-immunoprecipitates with the closely related VMAT(1) and with overexpressed VMAT(2). GST pull-down assays further identified three cytosolic domains of VMAT(2) involved in the interaction with TH and AADC. Furthermore, in vitro binding assays demonstrated that TH directly interacts with VMAT(2). Additionally, using fractionation and immunoisolation approaches, we demonstrate that TH and AADC associate with VMAT(2)-containing synaptic vesicles from rat brain. These vesicles exhibited specific TH activity. Finally, the coupling between synthesis and transport of DA into vesicles was impaired in the presence of fragments involved in the VMAT(2)/TH/AADC interaction. Taken together, our results indicate that DA synthesis can occur at the synaptic vesicle membrane, where it is physically and functionally coupled to VMAT(2)-mediated transport into vesicles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903816      PMCID: PMC2804354          DOI: 10.1074/jbc.M109.054510

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria.

Authors:  Jian Wang; Haiyan Lou; Courtney J Pedersen; Amanda D Smith; Ruth G Perez
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

2.  Cellular localization of tyrosine hydroxylase by immunohistochemistry.

Authors:  V M Pickel; T H Joh; P M Field; C G Becker; D J Reis
Journal:  J Histochem Cytochem       Date:  1975-01       Impact factor: 2.479

Review 3.  14-3-3 proteins: a family of versatile molecular regulators.

Authors:  V Obsilová; J Silhan; E Boura; J Teisinger; T Obsil
Journal:  Physiol Res       Date:  2008-05-13       Impact factor: 1.881

4.  Direct binding of GTP cyclohydrolase and tyrosine hydroxylase: regulatory interactions between key enzymes in dopamine biosynthesis.

Authors:  Kevin M Bowling; Zhinong Huang; Dong Xu; Faiza Ferdousy; Christopher D Funderburk; Nirmala Karnik; Wendi Neckameyer; Janis M O'Donnell
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

5.  Regulatory properties of soluble and particulate rat brain tyrosine hydroxylase.

Authors:  R T Kuczenski; A J Mandell
Journal:  J Biol Chem       Date:  1972-05-25       Impact factor: 5.157

6.  Methamphetamine-induced alteration in the physical state of rat caudate tyrosine hydroxylase.

Authors:  A J Mandell; S Knapp; R T Kuczenski; D S Segal
Journal:  Biochem Pharmacol       Date:  1972-10-15       Impact factor: 5.858

7.  On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine).

Authors:  J G Christenson; W Dairman; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

8.  Subcellular distribution of tyrosine hydroxylase and monoamine oxidase in the bovine caudate nucleus.

Authors:  T Nagatsu; I Nagatsu
Journal:  Experientia       Date:  1970

9.  Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.

Authors:  Eugene V Mosharov; Kristin E Larsen; Ellen Kanter; Kester A Phillips; Krystal Wilson; Yvonne Schmitz; David E Krantz; Kazuto Kobayashi; Robert H Edwards; David Sulzer
Journal:  Neuron       Date:  2009-04-30       Impact factor: 17.173

Review 10.  The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease.

Authors:  Kimmo A Michelsen; Jos Prickaerts; Harry W M Steinbusch
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

View more
  51 in total

1.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

Authors:  Lydia M Mexas; Virginia R Florang; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2011-04-14       Impact factor: 4.294

Review 2.  Tyrosine hydroxylase and regulation of dopamine synthesis.

Authors:  S Colette Daubner; Tiffany Le; Shanzhi Wang
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

3.  Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.

Authors:  Ana Jorge-Finnigan; Rune Kleppe; Kunwar Jung-Kc; Ming Ying; Michael Marie; Ivan Rios-Mondragon; Michael F Salvatore; Jaakko Saraste; Aurora Martinez
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

4.  Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency.

Authors:  Corina O Bondi; Ameer Y Taha; Jody L Tock; Nelson K B Totah; Yewon Cheon; Gonzalo E Torres; Stanley I Rapoport; Bita Moghaddam
Journal:  Biol Psychiatry       Date:  2013-07-25       Impact factor: 13.382

5.  Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling.

Authors:  Mark J Ferris; Marija Milenkovic; Shuai Liu; Catharine A Mielnik; Pieter Beerepoot; Carrie E John; Rodrigo A España; Tatyana D Sotnikova; Raul R Gainetdinov; Stephanie L Borgland; Sara R Jones; Amy J Ramsey
Journal:  Eur J Neurosci       Date:  2014-04-23       Impact factor: 3.386

6.  Analysis of synaptic proteins in the cerebrospinal fluid as a new tool in the study of inborn errors of neurotransmission.

Authors:  Sofia T Duarte; Carlos Ortez; Ana Pérez; Rafael Artuch; Angels García-Cazorla
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

7.  PC12 cells that lack synaptotagmin I exhibit loss of a subpool of small dense core vesicles.

Authors:  Robert D Adams; Amy B Harkins
Journal:  Biophys J       Date:  2014-12-16       Impact factor: 4.033

8.  Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity.

Authors:  Aram B Cholanians; Andy V Phan; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

Review 9.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

10.  Storage and uptake of D-serine into astrocytic synaptic-like vesicles specify gliotransmission.

Authors:  Magalie Martineau; Ting Shi; Julien Puyal; Ann M Knolhoff; Jérôme Dulong; Bruno Gasnier; Jürgen Klingauf; Jonathan V Sweedler; Reinhard Jahn; Jean-Pierre Mothet
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.